FDA approves first drug targeting polycythemia vera biology
The FDA approved weekly Mimrylo for adults with poorly controlled polycythemia vera, offering a new way to reduce phlebotomies while requiring close blood-count monitoring.
The FDA approved weekly Mimrylo for adults with poorly controlled polycythemia vera, offering a new way to reduce phlebotomies while requiring close blood-count monitoring.